Skip to main content
. 2014 Oct 4;105(11):1435–1441. doi: 10.1111/cas.12526

Fig 2.

Fig 2

(a,c,e) Overall survival curves of patients with NK/T-cell lymphoma (NKTCL) by latent membrane protein 1 (LMP1) expression (a), cutaneous lymphocyte antigen (CLA) expression (c) and cell-of-origin (e). (b,d,f) Progression-free survival curves of patients with NKTCL by LMP1 expression (b), CLA expression (d) and cell-of-origin (f).